Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03337269 · ClinicalTrials.gov registry record · NA
Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake
A NA study of HPV-Related Cervical Carcinoma, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 256
- Enrollment target
- 1
- Study location
NCT03337269: Completed NA study of HPV-Related Cervical Carcinoma, sponsored by University of Pennsylvania.
NCT03337269 is a NA study of HPV-Related Cervical Carcinoma that has completed, run by University of Pennsylvania. The registered enrollment target is 256 participants, roughly in line with the 269-participant average among 4 other HPV-Related Cervical Carcinoma trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03337269, a NA study of HPV-Related Cervical Carcinoma, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess the effectiveness of targeted educational interventions in increasing the acceptability and knowledge of the HPV vaccine among females ages 12 through 26. Subjects will be randomized to one of three study arms (no intervention, viewing an educational video or reading an educational handout) and then a questionnaire will be administered to assess knowledge and acceptability of the HPV vaccine. Subject charts will be reviewed to assess for initiation of the HPV vaccine.
Primary Outcome
Subject reported willingness to accept the HPV vaccination, as assessed through agreement or disagreement to the statement "I would be willing to accept the HPV vaccine today."
Conditions Studied
Interventions
- OTHER Control
- OTHER Educational video
- OTHER Educational handout
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2018-02-15 |
| Phase | NA |
What the finished NCT03337269 record still lists
NCT03337269 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 269-participant average among 4 other HPV-Related Cervical Carcinoma trials with a reported enrollment target.
The record links to 1 condition, with HPV-Related Cervical Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT03337269 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03337269 about?
NCT03337269 is a clinical study titled "Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake". This study aims to assess the effectiveness of targeted educational interventions in increasing the acceptability and knowledge of the HPV vaccine among females ages 12 through 26. Subjects will be randomized to one of three study arms (no intervention, viewing an educational video or reading an edu...
What is the current status of trial NCT03337269?
This trial is currently completed. It is a NA study. The enrollment target is 256 participants. The study started on 2017-03-01. Estimated completion is 2018-02-15.
What conditions does trial NCT03337269 study?
This clinical trial studies the following conditions: HPV-Related Cervical Carcinoma.
What interventions are being tested in trial NCT03337269?
The interventions under investigation include: Control (OTHER), Educational video (OTHER), Educational handout (OTHER).
Who is sponsoring clinical trial NCT03337269?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03337269 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HPV-Related Cervical Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
RECRUITING · Phase 1
-
Detecting HPV DNA in Anal and Cervical Cancers
RECRUITING
-
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
ACTIVE NOT RECRUITING · Phase 1
-
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT03793062 · 256 participants
Genetic and Epigenetic Basis of Chronic Wounds
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI